Matthew Harris
Patrimonio netto: 25 M $ in data 30/06/2026
Patrimonio netto: 25 M $ in data 30/06/2026
Matthew Harris is the founder and the Chief Scientific Officer of Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer of Gateway Capital Ltd. and a Non-Executive Director at Genera Biosystems Ltd. from 2007 to 2008.
Dr. Harris holds a doctorate from The Australian National University and an MBA from the Australian Graduate School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/08/2025 | 16.699.842 ( 4,48% ) | 25 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Fondatore | 01/01/2010 |
| Società | Posizione | Fine |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Direttore/Membro del Consiglio | 12/12/2008 |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Finance |
Genera Biosystems Ltd.
Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Manufactures, develops and commercializes multiplexed molecular diagnostic tests | Health Technology |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale